Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.

about

An Albumin-Oligonucleotide Assembly for Potential Combinatorial Drug Delivery and Half-Life Extension Applications.Welcome to volume 9 of Therapeutic Delivery.

P2860

Q47288556-2C9297AD-43A9-459A-8CE1-D302594A5003 Q50026104-9B65699A-1905-45D7-80DA-31885ABCC935

P2860

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.

Item

http://www.wikidata.org/entity/Q50616154

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Albumin-based drug delivery us ...... nsiderations and requirements.

@en

Albumin-based drug delivery us ...... nsiderations and requirements.

@nl

type

Item

label

Albumin-based drug delivery us ...... nsiderations and requirements.

@en

Albumin-based drug delivery us ...... nsiderations and requirements.

@nl

prefLabel

Albumin-based drug delivery us ...... nsiderations and requirements.

@en

Albumin-based drug delivery us ...... nsiderations and requirements.

@nl

P1476

Albumin-based drug delivery us ...... nsiderations and requirements.

@en

P2093

Birgitte Andersen

http://www.w3.org/2001/XMLSchema#string

Jason Cameron

http://www.w3.org/2001/XMLSchema#string

Karen Bunting

http://www.w3.org/2001/XMLSchema#string

Karl Nicholls

http://www.w3.org/2001/XMLSchema#string

Kenneth A Howard

http://www.w3.org/2001/XMLSchema#string

Malcolm J Saxton

http://www.w3.org/2001/XMLSchema#string

Matthias Kuhlmann

http://www.w3.org/2001/XMLSchema#string

Mikael B Caspersen

http://www.w3.org/2001/XMLSchema#string

P2860

The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan

Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics

Crystal structure of human serum albumin at 2.5 A resolution

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy

Determination of supplier-to-supplier and lot-to-lot variability in glycation of recombinant human serum albumin expressed in Oryza sativa

Site-Specific Albumination as an Alternative to PEGylation for the Enhanced Serum Half-Life in Vivo.

Site-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivo

Alkylation kinetics of proteins in preparation for two-dimensional maps: a matrix assisted laser desorption/ionization-mass spectrometry investigation.

Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding.

Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.

P304

511-519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/TDE-2017-0038

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28555530

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.

about

P2860

P2860

Albumin-based drug delivery using cysteine 34 chemical conjugates - important considerations and requirements.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921